The News Review:
- Ayush in National Health Care
- Illumina Inc. Files Resale Registration Statement for Previously…
- More avenues for life science graduates
Ayush in National Health Care
pib.nic.in – Aug 13, 2007
0pt;mso-bidi-font-size:11. 0pt;font-family:Arial’>The clinical research programme of the Council includes Diabetes Mellitus Hyperlipidemia Hypertension besity and such other conditions. Initial work on these projects has already started. The basis for taking areas for clinical research has always been National priorities as well as the areas in which Unani System of Medicine has potential… Initial work on these projects has already started. The basis for taking areas for clinical research has always been National priorities as well as the areas in which Unani System of Medicine has potential. 0pt;mso-bidi-font-size:11. 0pt;font-family:Arial’>. 0pt;font-family:Arial’>Homoeopathy.
Illumina Inc. Files Resale Registration Statement for Previously…
Genetic Engineering News – Genetic Engineering News (press release) – Aug 13, 2007
About Illumina Illumina is a leading developer manufacturer and marketer ofnext-generation life science tools and integrated systems for thelarge scale analysis of genetic variation and biological function. Using our proprietary technologies we provide a comprehensive line ofproducts and services that currently serve the sequencing genotypingand gene expression markets and we expect to enter the market formolecular diagnostics. ur customers include leading genomic researchcenters pharmaceutical companies academic institutions clinicalresearch organizations and biotechnology companies. ur tools provideresearchers around the world with the performance throughput costeffectiveness and flexibility necessary to perform the billions ofgenetic tests needed to extract valuable medical information fromadvances in genomics and proteomics. We believe this information willenable researchers to correlate genetic variation and biologicalfunction which will enhance drug discovery and clinical researchallow diseases to be detected earlier and permit better choices ofdrugs for individual patients. “Safe Harbor” Statement under the Private Securities LitigationReform Act of 1995: this release may contain forward-lookingstatements that involve risks and uncertainties. Among the importantfactors that could cause actual results to differ materially fromthose in any forward-looking statements are the costs and outcome ofIllumina’s litigation with Affymetrix and our ability (i) to integrateeffectively our recent acquisition of Solexa Inc.
More avenues for life science graduates
Hindu – Aug 13, 2007
New drugs Drug Discovery and Medicinal Chemistry a specialisation in pharmaceutical sciences that enables a researcher to invent and synthesize new drugs. Although many universities offer medicinal chemistry as discipline in post graduation for pharmacy students masters students hardly get to touch upon the ‘in silico’ approach to Drug Discovery and Design. Since Drug Discovery is a multidisciplinary domain researchers from different disciplines form a R&D team in a Drug discovery projects and ‘in silico’ drug discovery remains the first and most important step in this process in order to narrow down the number of compounds to be synthesized and studied in wet lab and subsequently in clinical research. Every contract research organisation pharmaceutical and biotech R&D requires establishing a division to monitor patents and mine data from scientific literature. It is also important for understanding patent issues before companies start their research work in a particular area. Multinational software companies develop scientific software required to run ‘in silico’ experiments. Although it is more of a computer programming domain life sciences students are acquiring required programming skills and quality assurance in software development as well.
